The latest recommendations on the use of new oral anticoagulants in routine practice

The latest recommendations on the use of new oral anticoagulants in routine practice

Show other versions (1)

The use of non-vitamin K antagonist oral anticoagulants (NOACs) has become a breakthrough in anticoagulant treatment and it is expected to rise significantly in upcoming years. The use of conventional anticoagulants have several limitations: subcutaneous administration of heparin, or close monitorin...

Full description

Bibliographic Details
Main Authors:	Michał Witkowski, Magdalena Witkowska, Piotr Smolewski
Format:	Article
Language:	English
Published:	Index Copernicus International S.A. 2016-02-01
Series:	Postępy Higieny i Medycyny Doświadczalnej
Subjects:	nowe leki przeciwkrzepliwe migotanie przedsionków anticoagulant treatment dabigatran rywaroksaban apiksaban
Online Access:	http://phmd.pl/gicid/01.3001.0009.6782

Similar Items

The latest recommendations on the use of new oral anticoagulants in routine practice
by: Michał Witkowski, et al.
Published: (2016-02-01)

Zaburzenia poznawcze w przebiegu migotania przedsionków
by: Krzysztof M. Wilczyński, et al.
Published: (2017-09-01)

Profilaktyka krwawień z przewodu pokarmowego u chorych leczonych lekami hamującymi układ krzepnięcia z przyczyn kardiologicznych
by: Elżbieta Deptuła-Krawczyk, et al.
Published: (2010-09-01)

Current Treatments of Deep Venous Thrombosis
by: Goknur Tekin
Published: (2015-12-01)

Przygotowanie chorych ze schorzeniami układu sercowo-naczyniowego do zabiegów endoskopowych
by: Elżbieta Deptuła-Krawczyk, et al.
Published: (2010-09-01)

Oral and parenteral anticoagulants: New kids on the block
by: S Aditya
Published: (2012-01-01)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
by: Hu TY, et al.
Published: (2016-02-01)

Are Three Weeks of Oral Anticoagulation Sufficient for Safe Cardioversion in Atrial Fibrillation?
by: Stefan Naydenov, et al.
Published: (2021-05-01)

Dabigatran etexilate - A novel oral anticoagulant for bleeding complications
by: Himabindu Reddy, et al.
Published: (2015-09-01)

Factors driving the use of warfarin and non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation
by: Mu-Mei Hu, et al.
Published: (2017-04-01)

Direct oral anticoagulants: A new chapter in anticoagulation therapy
by: Stepanović-Petrović Radica, et al.
Published: (2020-01-01)

New versus Old Oral Anticoagulants: How Can We Set the Scale Needle? Considerations on a Case Report
by: Francesca Antonia Arcadi, et al.
Published: (2019-03-01)

Fully automated thromboelastograph TEG 6s to measure anticoagulant effects of direct oral anticoagulants in healthy male volunteers
by: Ramin Artang, et al.
Published: (2019-07-01)

The Anticoagulated trauma patient in the age of the direct oral anticoagulants: a Canadian perspective
by: Brendan Wood, et al.
Published: (2017-08-01)

PHARMACOGENETIC ASPECTS OF NEW ORAL ANTICOAGULANTS APPLICATION
by: A. V. Kryukov, et al.
Published: (2017-07-01)

A novel prothrombin time method to measure all non-vitamin K-dependent oral anticoagulants (NOACs)
by: Tomas L. Lindahl, et al.
Published: (2017-07-01)

Evaluation of bleeding in patients receiving direct oral anticoagulants
by: Hellenbart EL, et al.
Published: (2017-08-01)

Atrial fibrillation and stroke in the perspective of new oral anticoagulants
by: Demet Funda Baş, et al.
Published: (2013-02-01)

NEW ORAL ANTICOAGULANTS: FOCUS ON THE SAFETY
by: D. A. Napalkov, et al.
Published: (2015-09-01)

Direct-Acting Oral Anticoagulants and Their Reversal Agents—An Update
by: Stephanie A. Kustos, et al.
Published: (2019-10-01)

New Direct Oral Anticoagulants (DOAC) and Their Use Today
by: Heike Schwarb, et al.
Published: (2016-03-01)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
by: Raquel Ferrandis, et al.
Published: (2020-04-01)

Multichamber intracardiac thrombosis during novel oral anticoagulation reversal with activated prothrombin complex concentrate infusion
by: Philip L. Mar, MD, PharmD, et al.
Published: (2020-03-01)

Assessment of novel oral anticoagulant use within a community teaching hospital
by: Sultan Alghadeer, et al.
Published: (2017-01-01)

Viscoelastometry for detecting oral anticoagulants
by: Philipp Groene, et al.
Published: (2021-03-01)

Old and New anticoagulants: The beginning of a new era?
by: Fidel Cáceres Loriga, et al.
Published: (2011-01-01)

Safety of radial coronary angiography with uninterrupted direct-acting oral anticoagulant treatment
by: Tuğba Kemaloğlu Öz, et al.
Published: (2019-01-01)

A Review of the Incidence Diagnosis and Treatment of Spontaneous Hemorrhage in Patients Treated with Direct Oral Anticoagulants
by: Kulothungan Gunasekaran, et al.
Published: (2020-09-01)

Hepatotoxicity of New Oral Anticoagulants
by: A. R. Kasimova, et al.
Published: (2018-09-01)

The treatment of venous thromboembolism with new oral anticoagulants
by: Davide Imberti
Published: (2013-12-01)

Direct oral anticoagulants: first airbag
by: A. N. Sokolova, et al.
Published: (2019-04-01)

DATA OF CLINICAL PRACTICE AS A TOOL FOR CHOICE OF DIRECT ORAL ANTICOAGULANT
by: D. А. Napalkov, et al.
Published: (2017-03-01)

THE EFFICACY AND SAFETY OF NEW ORAL ANTICOAGULANTS IN PATIENTS WITH ATRIAL FIBRILLATION IN CLINICAL PRACTICE
by: S. V. Moiseev
Published: (2016-05-01)

Prescribing of direct oral anticoagulants and warfarin to older people with atrial fibrillation in UK general practice: a cohort study
by: Anneka Mitchell, et al.
Published: (2021-08-01)

New safety standards for anticoagulant therapy in the treatment of atrial fibrillation
by: E. I. Baranova
Published: (2018-11-01)

Oral anticoagulants in the prevention of thromboembolic complications in cardiac patients: analysis of use in the Russian Federation
by: A. A. Gruzdeva, et al.
Published: (2020-05-01)

New Pharmacogenetic Markers to Predict the Risk of Bleeding During Taking of Direct Oral Anticoagulants
by: K. B. Mirzaev, et al.
Published: (2020-11-01)

Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
by: Masahiro Yasaka, et al.
Published: (2020-03-01)

EFFICACY AND SAFETY OF THE ORAL ANTICOAGULANTS IN THE MANAGEMENT OF VENOUS THROMBOEMBOLISM: INDIRECT COMPARISON
by: V. I. Petrov, et al.
Published: (2016-12-01)

Analiza nawyków i zachowań związanych ze stosowaniem leków oryginalnych i generycznych = The analysis of behaviour related to the use of original and generic drugs
by: Piotr Kozłowski, et al.
Published: (2015-08-01)

Cannot write session to /tmp/vufind_sessions/sess_3dt6el3o8oe75lk1f2irj3732k